Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer to buy Therachon for $340 million upfront, gaining experimental drug for achondroplasia

firstwordpharmaMay 09, 2019

Tag: Pfizer , Therachon , Experimental Drug

PharmaSources Customer Service